Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis

Gastroenterology Clinics of North America

Volumn 37, Issue 2, 2008, Pages 479-484

  Mendes, Flavia ^a   Lindor, Keith D ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CARBONATE DEHYDRATASE II; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; LACTOFERRIN; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

AUTOIMMUNE DISEASE; CHOLANGITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; LIVER DISEASE; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEROLOGY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AUTOANTIBODIES; HUMANS; LIVER CIRRHOSIS, BILIARY;

EID: 43549100421     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.02.006     Document Type: Review

References (20)

1. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 12 (2005) 1261-1273
2. Czaja A.J., Carpenter H.A., Santrach P.J., et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31 6 (2000) 1231-1238
3. Vierling J.M. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis 8 1 (2004) 177-194
4. Invernizzi P., Crosignani A., Battezzati P.M., et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25 5 (1997) 1090-1095
5. Michieletti P., Wanless I.R., Katz A., et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35 2 (1994) 260-265
6. Nakajima M., Shimizu H., Miyazaki A., et al. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?. J Gastroenterol 34 5 (1999) 607-612
7. Kitami N., Komada T., Ishii H., et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 34 6 (1995) 496-501
8. Kim W.R., Poterucha J.J., Jorgensen R.A., et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26 1 (1997) 22-26
9. Lacerda M.A., Ludwig J., Dickson E.R., et al. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90 2 (1995) 247-249
10. O'Donohue J., Wong T., Portmann B., et al. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur J Gastroenterol Hepatol 14 10 (2002) 1143-1150
11. Watanabe S., Deguchi A., Uchida N., et al. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy. Hepatol Res 19 1 (2001) 41-51
12. Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastroenterol 14 4 (2000) 601-613
13. Lindor K.D., Dickson E.R., Baldus W.P., et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106 5 (1994) 1284-1290
14. Poupon R.E., Poupon R., and Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 330 19 (1994) 1342-1347
15. Markus B.H., Dickson E.R., Grambsch P.M., et al. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 320 26 (1989) 1709-1713
16. Starzl T.E., Demetris A.J., and Van Thiel D. Liver transplantation (1). N Engl J Med 321 15 (1989) 1014-1022
17. Gisbert J.P., Jones E.A., Pajares J.M., et al. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?. Aliment Pharmacol Ther 17 1 (2003) 17-27
18. Christensen E., Altman D.G., Neuberger J., et al. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology 105 6 (1993) 1865-1876
19. Dickson E.R., Grambsch P.M., Fleming T.R., et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10 1 (1989) 1-7
20. Rydning A., Schrumpf E., Abdelnoor M., et al. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 25 2 (1990) 119-126